X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (20) 20
hematology, oncology and palliative medicine (17) 17
humans (17) 17
radiology (17) 17
radiology, nuclear medicine & medical imaging (17) 17
radiotherapy (17) 17
index medicus (14) 14
radiology and nuclear medicine (14) 14
female (13) 13
neoplasms (13) 13
care and treatment (10) 10
radiotherapy dosage (10) 10
cancer (9) 9
cervical cancer (9) 9
middle aged (9) 9
radiotherapy, intensity-modulated - methods (9) 9
aged (8) 8
diseases (8) 8
therapy (8) 8
uterine cervical neoplasms - radiotherapy (8) 8
analysis (7) 7
intensity-modulated radiotherapy (7) 7
medicine (7) 7
radiation (7) 7
radiation doses (7) 7
toxicity (7) 7
body (6) 6
patients (6) 6
pelvis (6) 6
radiation-therapy (6) 6
adult (5) 5
carcinoma (5) 5
computerized tomography (5) 5
concurrent chemotherapy (5) 5
gynecologic malignancies (5) 5
imrt (5) 5
male (5) 5
nuclear medicine (5) 5
organs (5) 5
treatment outcome (5) 5
tumor burden (5) 5
uterine cervical neoplasms - pathology (5) 5
aged, 80 and over (4) 4
antineoplastic agents - therapeutic use (4) 4
bone marrow (4) 4
bone marrow - radiation effects (4) 4
cancer patients (4) 4
carcinomas (4) 4
chemotherapy (4) 4
cisplatin (4) 4
clinical trials (4) 4
combined modality therapy - methods (4) 4
images (4) 4
irradiation (4) 4
pelvic radiotherapy (4) 4
radiotherapy planning, computer-assisted - methods (4) 4
radiotherapy, intensity-modulated - adverse effects (4) 4
rectum (4) 4
surgery (4) 4
urogenital system diseases (4) 4
acute hematologic toxicity (3) 3
article (3) 3
bladder (3) 3
bone-marrow (3) 3
brachytherapy (3) 3
chemoradiotherapy (3) 3
cisplatin - therapeutic use (3) 3
combined therapy (3) 3
follow-up studies (3) 3
hematologic toxicity (3) 3
image-guided radiotherapy (3) 3
intensity-modulated radiation therapy (3) 3
lymph nodes (3) 3
medical colleges (3) 3
metastases (3) 3
organs at risk - radiation effects (3) 3
probability (3) 3
radiosurgery - methods (3) 3
radiotherapy, intensity-modulated - standards (3) 3
regression analysis (3) 3
testing (3) 3
tumors (3) 3
urinary bladder (3) 3
uterine cervical neoplasms - diagnostic imaging (3) 3
uterine cervical neoplasms - drug therapy (3) 3
uterus (3) 3
vertebrae (3) 3
anal cancer (2) 2
animal tissues (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
bone marrow - drug effects (2) 2
brain (2) 2
brain neoplasms - pathology (2) 2
brain neoplasms - secondary (2) 2
brain neoplasms - surgery (2) 2
chemoradiation (2) 2
cisplatin - administration & dosage (2) 2
combined modality therapy - adverse effects (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 71, Issue 2, pp. 428 - 434
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 5, pp. 1436 - 1445
Purpose To evaluate disease outcomes and toxicity in cervical cancer patients treated with pelvic intensity-modulated radiation therapy (IMRT). Methods and... 
Radiology | Hematology, Oncology and Palliative Medicine | Intensity-modulated radiation therapy | Cervical cancer | CANCER PATIENTS | GYNECOLOGIC-ONCOLOGY-GROUP | PARAAORTIC LYMPH-NODES | BONE-MARROW | CONE-BEAM CT | UTERINE CERVIX | ACUTE HEMATOLOGIC TOXICITY | ONCOLOGY | HIGH-RISK | CONCURRENT CHEMOTHERAPY | DOSIMETRIC ANALYSIS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Confidence Intervals | Follow-Up Studies | Humans | Middle Aged | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Urinary Bladder - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Neoplasm Staging - methods | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Brachytherapy | Uterine Cervical Neoplasms - mortality | Uterine Cervical Neoplasms - radiotherapy | Radiotherapy, Intensity-Modulated - methods | Hysterectomy - methods | Carboplatin - administration & dosage | Survival Rate | Treatment Outcome | Rectum - radiation effects | Radiation Dosage | Aged | Antimitotic agents | Medical colleges | Care and treatment | Patient outcomes | Radiation | Radiotherapy | Antineoplastic agents | Cancer | Toxicity | Clinical trials | Adjuvants | Oncology | Hysterectomy | Pelvis | Survival | Urinary bladder | Intestine | Rectum | Cervical carcinoma | Index Medicus | GASTROINTESTINAL TRACT | LARGE INTESTINE | NEOPLASMS | CLINICAL TRIALS | RECTUM | DIGESTIVE SYSTEM | RADIATION DOSES | TOXICITY | INTESTINES | MEDICINE | NUCLEAR MEDICINE | ORGANS | URINARY TRACT | TESTING | DISEASES | THERAPY | DOSES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | BRACHYTHERAPY | BODY | RADIOLOGY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 70, Issue 5, pp. 1431 - 1437
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 79, Issue 3, pp. 800 - 807
Purpose To test the hypothesis that increased pelvic bone marrow (BM) irradiation is associated with increased hematologic toxicity (HT) in cervical cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | Bone marrow | Hematologic toxicity | Normal tissue complication probability | Cervical cancer | GYNECOLOGIC-ONCOLOGY-GROUP | INTENSITY-MODULATED RADIOTHERAPY | PELVIC RADIATION-THERAPY | TREATMENT TIME | PHASE-III TRIAL | UTERINE CERVIX | ONCOLOGY | BONE-MARROW REGENERATION | CONCURRENT CHEMOTHERAPY | ANAL CANCER | SQUAMOUS-CELL CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Humans | Middle Aged | Uterine Cervical Neoplasms - blood | Antineoplastic Agents - therapeutic use | Bone Marrow - radiation effects | Pelvis | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Neutrophils - radiation effects | Antineoplastic Agents - adverse effects | Female | Leukocyte Count | Bone Marrow - drug effects | Body Mass Index | Radiotherapy Dosage | Uterine Cervical Neoplasms - radiotherapy | Neutrophils - drug effects | Probability | Uterine Cervical Neoplasms - drug therapy | Models, Statistical | Radiation Injuries - complications | Combined Modality Therapy - adverse effects | Hemoglobin A - analysis | Platelet Count | Cisplatin - therapeutic use | Combined Modality Therapy - methods | Body mass index | Leukopenia | Toxicity | Radiation | Data processing | Leukocytes | Regression analysis | Radiotherapy | Cisplatin | Index Medicus | BODY FLUIDS | NEOPLASMS | BIOLOGICAL MATERIALS | VALIDATION | BONE MARROW | TOXICITY | ANIMAL TISSUES | UROGENITAL SYSTEM DISEASES | SIMULATION | MEDICINE | ORGANS | PROBABILITY | TESTING | DISEASES | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLOOD CELLS | PELVIS | HEMATOPOIETIC SYSTEM | BODY | MATERIALS | COMBINED THERAPY | BLOOD | hematologic toxicity | cervical cancer | bone marrow | normal tissue complication probability
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 71, Issue 5, pp. 1504 - 1510
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 3, pp. 1039 - 1041
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 1, pp. 273 - 280
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 1, pp. e81 - e86
Purpose To test the hypothesis that increased bowel radiation dose is associated with acute gastrointestinal (GI) toxicity in cervical cancer patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Gastrointestinal toxicity | IMRT | Chemoradiation | Cervical cancer | NTCP | SURGERY | SMALL-BOWEL TOXICITY | PELVIC RADIOTHERAPY | VOLUME | CHEMORADIOTHERAPY | CHEMOTHERAPY | IRRADIATION | WOMEN | ONCOLOGY | HIGH-RISK | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Organs at Risk - radiation effects | Chemoradiotherapy - adverse effects | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Gastrointestinal Tract - radiation effects | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Gastrointestinal Tract - pathology | Radiotherapy, Intensity-Modulated - adverse effects | Regression Analysis | Cisplatin - therapeutic use | Antineoplastic Agents - adverse effects | Cisplatin - adverse effects | Female | Radiation Injuries - pathology | Retrospective Studies | Uterine Cervical Neoplasms - therapy | Antimitotic agents | Cancer patients | Care and treatment | Chemotherapy | Nuclear radiation | Analysis | Radiation | Radiotherapy | Antineoplastic agents | Cisplatin | Cancer | Index Medicus | Intestine | Toxicity | Oncology | Models | PATIENTS | PROBABILITY | NEOPLASMS | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | RADIOTHERAPY | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 91 - 97
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 2, pp. 435 - 441
Purpose To report on the acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with a unique technique of image-guided radiotherapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Intensity-modulated radiation therapy (IMRT) | Adjuvant | Salvage | Image-guided radiotherapy | Prostate cancer | LOCALIZATION | RANDOMIZED CLINICAL-TRIAL | RADICAL PROSTATECTOMY | RADIATION-THERAPY IMRT | BIOCHEMICAL CONTROL | GENITOURINARY TOXICITY | POSTPROSTATECTOMY PATIENTS | ONCOLOGY | SALVAGE RADIOTHERAPY | ADJUVANT RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PREDICTIVE FACTORS | Radiotherapy Dosage | Severity of Illness Index | Multivariate Analysis | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Prostatic Neoplasms - surgery | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Urogenital System - radiation effects | Postoperative Period | Gastrointestinal Tract - radiation effects | Male | Radiotherapy, Intensity-Modulated - adverse effects | Cone-Beam Computed Tomography | Radiotherapy, Adjuvant - methods | Prostatectomy | Radiation Injuries - pathology | Aged | Salvage Therapy - methods | Radiotherapy | Analysis | Radiation | Index Medicus | PROSTATE | TOMOGRAPHY | DIAGNOSTIC TECHNIQUES | NEOPLASMS | MALE GENITALS | TOXICITY | MEDICINE | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | ORGANS | DISEASES | THERAPY | GLANDS | IMAGES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | RADIOLOGY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 5, pp. 1500 - 1505
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 3, pp. 912 - 919
Purpose To study the effects of increasing pelvic bone marrow (BM) radiation dose on acute hematologic toxicity in patients undergoing chemoradiotherapy, using... 
Radiology | Hematology, Oncology and Palliative Medicine | Hematologic toxicity | Chemoradiotherapy | Deformable image registration | Cervical cancer | Principal component analysis | INTENSITY-MODULATED RADIOTHERAPY | PELVIC RADIATION | RANDOMIZED-TRIAL | MITOMYCIN | FLUOROURACIL | THERAPY | CISPLATIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Bone Marrow - radiation effects | Pelvis | Principal Component Analysis - methods | Leukocytes - radiation effects | Female | Bone Marrow - diagnostic imaging | Leukocyte Count | Bone Marrow - drug effects | Radiotherapy Dosage | Uterine Cervical Neoplasms - radiotherapy | Radiotherapy, Intensity-Modulated - methods | Linear Models | Uterine Cervical Neoplasms - drug therapy | Combined Modality Therapy - adverse effects | Leukopenia - pathology | Radiography | Pelvic Bones - radiation effects | Bone Marrow Cells | Cisplatin - therapeutic use | Leukocytes - drug effects | Combined Modality Therapy - methods | Leukopenia - etiology | Pelvic Bones - diagnostic imaging | Care and treatment | Radiotherapy | Analysis | Radiation | Cancer | Index Medicus | Bone marrow | NEOPLASMS | BONE MARROW | RADIATION DOSES | TOXICITY | ANIMAL TISSUES | UROGENITAL SYSTEM DISEASES | MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | HEMATOPOIETIC SYSTEM | BODY | COMBINED THERAPY | chemoradiotherapy | deformable image registration | hematologic toxicity | cervical cancer | principal component analysis
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 68, Issue 1, pp. 111 - 118
Journal Article